K C Cundy - Concepedia

Concepedia

Author

K C Cundy

Gilead Sciences (United States)

Also Known As

K C Cundy, K Cundy, K. C. CUNDY, K. C. Cundy, K. Cundy, K.C. Cundy, K. C. Cundy, Kc Cundy

26

Publications

2.4K

Citations

18

H-Index

36

Concepts

All Affiliations

Gilead Sciences (United States)University of California, Berkeley Johns Hopkins Medicine Johns Hopkins University University of Kentucky

KC

About

K C Cundy is an author at Gilead Sciences (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.6K
2	Biochemistry	6	6	1.2K
3	Natural Sciences	2	2	236
4	Biomolecular Engineering	2	2	236
5	Immunology	2	2	288

K C Cundy

×

19

Publications

2.4K

Citations

18

H-Index

	Year	Citations
Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain. R. Kohen, Yumi Yamamoto, K C Cundy, Proceedings of the National Academy of Sciences Lipid PeroxidationAntioxidant ActivityRedox BiologyOxidative StressAscorbic Acid	1988	781
Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients K C Cundy, Brent G. Petty, John F. Flaherty, Antimicrobial Agents and Chemotherapy Intravenous CidofovirMedicineHigher Cidofovir DosesImmunologyAntiviral Drug Development	1995	202
(S)-1-[3-Hydroxy-2-(Phosphonylmethoxy)propyl]cytosine (Cidofovir): Results of a Phase I/II Study of a Novel Antiviral Nucleotide Analogue Jacob Lalezari, William Drew, E. Glutzer, The Journal of Infectious Diseases	1995	196
Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients K C Cundy, Patricia Barditch‐Crovo, Robert Walker, Antimicrobial Agents and Chemotherapy	1995	131
Unexpected pehnomenon in the high-performance liquid chromatographic anlaysis of racemic 14C-labelled nicotine: Separation of enantiomers in a totally achiral system K C Cundy, Peter A. Crooks Journal of Chromatography A Racemic 14C-labelled NicotineBiochemistryMedicineNicotineBioanalysis	1983	126
Synthesis, in Vitro Biological Evaluation and Oral Bioavailability of 9-[2-(Phosphonomethoxy)Propyl]Adenine (PMPA) Prodrugs Mn Arimilli, C. U. KIM, Joseph P. Dougherty, Antiviral chemistry & chemotherapy Pharmaceutical ScienceOral BioavailabilityPharmacotherapyAntiviral DrugPharmaceutical Chemistry	1997	122
Detection of DNA adducts by high-performance liquid chromatography with electrochemical detection Jung‐Won Park, K C Cundy, B N Ames Carcinogenesis Dna DamageDna Base DamageDna AnalysisMolecular BiologyNucleic Acid Amplification Test	1989	114
Anti‐Human Immunodeficiency Virus (HIV) Activity, Safety, and Pharmacokinetics of Adefovir Dipivoxil (9‐[2‐(bis‐pivaloyloxymethyl)‐phosphonylmethoxyethyl]adenine) in HIV‐Infected Patients Patricia Barditch‐Crovo, J J Toole, C. W. Hendrix, The Journal of Infectious Diseases	1997	99
Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects M. Wachsman, Brent G. Petty, K C Cundy, Antiviral Research	1996	95
1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl] cytosine, an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivo N. Bischofberger, Michael J. M. Hitchcock, M S Chen, Antimicrobial Agents and Chemotherapy	1994	88

Page 1